Haemonetics Corp. (HAE)
Haemonetics Market Cap : 2.845B for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 195.10B |
| Boston Scientific Corp. | 110.57B |
| Solventum Corp. | 12.65B |
| DexCom, Inc. | 28.12B |
| Masimo Corp. | 9.407B |
Market Cap Related Metrics
| PE Ratio | 16.82 |
| PS Ratio | 2.235 |
| PEG Ratio | 0.3892 |
| Price to Book Value | 3.122 |
| Price to Free Cash Flow | 9.564 |
| Price | 61.23 |
| Earnings Yield | 5.94% |
| PEGY Ratio | 0.3892 |
| Operating PE Ratio | 12.10 |
| Normalized PE Ratio | 16.79 |